| |
| |
|
| Insider
Information: |
Mckinnell Henry A |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
3,072,534 |
|
|
Indirect Shares
|
253,582 |
|
|
| Direct
Value |
$108,322,857 |
|
|
|
Indirect Value
|
$7,506,027 |
|
|
| Total
Shares |
3,326,116 |
|
|
| Total
Value |
$115,828,884 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Moodys Corp |
MCO |
Director |
2021-03-18 |
89,488 |
2003-09-25 |
0 |
Premium* |
|
|
Pfizer Inc |
PFE |
Director |
2007-02-28 |
2,134,851 |
2007-02-28 |
253,582 |
Premium* |
|
|
Exxon Mobil Corp |
XOM |
Director |
2007-01-03 |
36,400 |
2004-05-26 |
0 |
Premium* |
|
|
Angiotech Pharmaceuticals Inc(USA) |
ANPIQ |
Director |
2008-05-12 |
50,000 |
|
0 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
CEO and Chairman of th... |
2013-10-24 |
0 |
|
0 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
Director |
2019-01-02 |
689,046 |
2016-08-22 |
0 |
Premium* |
|
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-05-20 |
72,749 |
2016-11-03 |
0 |
Premium* |
|
|
Federal Street Acquisition Corp |
FSAC |
Director |
2019-01-04 |
0 |
2019-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MCO |
Moodys Corp |
Director |
– • – |
2012-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,626 |
103,943 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2012-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
798 |
104,883 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
25,000 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2013-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
35,000 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2013-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,877 |
111,606 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,451 |
114,604 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2015-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,092 |
117,218 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2016-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,518 |
120,338 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2016-08-05 |
5 |
GD |
$0.00 |
$0 |
D/D |
40,436 |
80,600 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • – |
2016-09-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,586 |
340,314 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2016-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,306 |
31,306 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,142 |
82,742 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
12,912 |
44,218 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • – |
2017-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,987 |
658,290 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,493 |
84,822 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$54,996 |
D/D |
27,596 |
689,046 |
0 |
- |
|
| FSAC |
Federal Street Acquisitio... |
Director |
– • – |
2019-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| FSAC |
Federal Street Acquisitio... |
Director |
– • – |
2019-01-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(25,000) |
0 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,440 |
86,796 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2019-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,421 |
52,639 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,724 |
60,363 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2020-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,660 |
65,023 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2022-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,726 |
72,749 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • – |
2016-08-22 |
4 |
B |
$2.95 |
$987,448 |
D/D |
334,728 |
334,728 |
2.39 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • – |
2017-01-18 |
4 |
B |
$3.17 |
$992,175 |
D/D |
312,989 |
653,303 |
2.39 |
- |
|
148 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
